THROMBATE III PWS IV 500IU/VIAL DIN 02020580
Status: Cancelled Post Market
Holder: MILES INC. - PHARMACEUTICAL DIVISION
Molecule: ANTITHROMBIN III (HUMAN)
Health Canada record
| Active ingredient(s) | ANTITHROMBIN III (HUMAN) 500 UNIT |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | B01AB02 ANTITHROMBIN |
| Original market date | 31-Dec-1995 |
| Current status date | 25-Sep-1998 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ANTITHROMBIN III (HUMAN)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02237810 | ANTITHROMBIN III NF | TAKEDA CANADA INC | Powder For Solution; Kit | ANTITHROMBIN III (HUMAN) 1100 UNIT | Marketed |
| 02237811 | ANTITHROMBIN III NF | TAKEDA CANADA INC | Kit; Powder For Solution | ANTITHROMBIN III (HUMAN) 550 UNIT | Marketed |
| 02189135 | THROMBATE III | GRIFOLS THERAPEUTICS LLC | Powder For Solution | ANTITHROMBIN III (HUMAN) 500 UNIT | Approved |
| 02237812 | ANTITHROMBIN III IMMUNO | BAXTER AG | Powder For Solution | ANTITHROMBIN III (HUMAN) 1650 UNIT; WATER 30 ML | Cancelled Post Market |
| 02189143 | THROMBATE III | GRIFOLS THERAPEUTICS LLC | Powder For Solution | ANTITHROMBIN III (HUMAN) 1000 UNIT | Cancelled Post Market |
| 02020572 | THROMBATE III PWS IV 1000IU/VIAL | MILES INC. - PHARMACEUTICAL DIVISION | Powder For Solution | ANTITHROMBIN III (HUMAN) 1000 UNIT | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 5897 | 1994-03-31 | New Drug Submission (NDS) |